Bernhard Mittemeyer

Corporate Officer/Principal bei Texas Tech University Health Sciences Center

93 Jahre

Consumer Services

Health Technology

Aktive Positionen von Bernhard Mittemeyer

Unternehmen	Position	Beginn	Ende
Texas Tech University Health Sciences Center	Corporate Officer/Principal	-	-

Unternehmen	Position	Beginn	Ende
Hemobiotech, Inc. Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX.	Direktor/Vorstandsmitglied	10.12.2004	-
	Independent Dir/Board Member	10.12.2004	-

Temple University (Pennsylvania)

Doctorate Degree

International

Vereinigte Staaten

Operativ

Director/Board Member	1
Independent Dir/Board Member	1
Doctorate Degree	1

Sektoral

Consumer Services	3
Health Technology	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	1
Hemobiotech, Inc. Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX.	Health Technology

Private Unternehmen

Health Technology